Quarterly Statement Of Cash Flows

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7310818

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
As at
2022-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
55,000,000 JPY
122,000,000 JPY
Interest and dividends received
13,000,000 JPY
11,000,000 JPY
Interest paid
-4,000,000 JPY
-4,000,000 JPY
Income taxes paid
-7,000,000 JPY
-3,000,000 JPY
Net cash provided by (used in) operating activities
256,000,000 JPY
126,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-72,000,000 JPY
-27,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
JPY
Proceeds from sale of investment securities
JPY
287,000,000 JPY
Net cash provided by (used in) investing activities
-135,000,000 JPY
707,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-603,000,000 JPY
-589,000,000 JPY
Dividends paid
-1,000,000 JPY
0 JPY
Other, net
-2,000,000 JPY
-2,000,000 JPY
Net cash provided by (used in) financing activities
-562,000,000 JPY
827,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
113,000,000 JPY
53,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-327,000,000 JPY
1,714,000,000 JPY
Cash and cash equivalents
4,916,000,000 JPY
5,244,000,000 JPY
4,511,000,000 JPY
2,797,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.